These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 30526680

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.
    Mavropoulos A, Simopoulou T, Varna A, Liaskos C, Katsiari CG, Bogdanos DP, Sakkas LI.
    Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243
    [Abstract] [Full Text] [Related]

  • 29. High expression of circulating exosomal PD-L1 contributes to immune escape of hepatocellular carcinoma and immune clearance of chronic hepatitis B.
    Lin X, Shao H, Tang Y, Wang Q, Yang Z, Wu H, Xing T.
    Aging (Albany NY); 2024 Jul 17; 16(14):11373-11384. PubMed ID: 39028365
    [Abstract] [Full Text] [Related]

  • 30. VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
    Zhang M, Pang HJ, Zhao W, Li YF, Yan LX, Dong ZY, He XF.
    BMC Cancer; 2018 May 02; 18(1):511. PubMed ID: 29720116
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Differential expression of Tim-3, PD-1, and CCR5 on peripheral T and B lymphocytes in hepatitis C virus-related hepatocellular carcinoma and their impact on treatment outcomes.
    Zahran AM, Hetta HF, Rayan A, Eldin AS, Hassan EA, Fakhry H, Soliman A, El-Badawy O.
    Cancer Immunol Immunother; 2020 Jul 02; 69(7):1253-1263. PubMed ID: 32170378
    [Abstract] [Full Text] [Related]

  • 35. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients.
    Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX, Cai XY, He HW, Jin JJ, Cheng YF, Fan J, Sun J, Qiu SJ.
    J Gastroenterol Hepatol; 2013 Sep 02; 28(9):1555-64. PubMed ID: 23517245
    [Abstract] [Full Text] [Related]

  • 36. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment.
    Li Q, Ma L, Shen S, Guo Y, Cao Q, Cai X, Feng J, Yan Y, Hu T, Luo S, Zhou L, Peng B, Yang Z, Hua Y.
    J Exp Clin Cancer Res; 2019 Jul 11; 38(1):303. PubMed ID: 31296243
    [Abstract] [Full Text] [Related]

  • 37. Dynamic analysis of tumor-associated immune cells in DEN-induced rat hepatocellular carcinoma.
    Song S, Yuan P, Li P, Wu H, Lu J, Wei W.
    Int Immunopharmacol; 2014 Oct 11; 22(2):392-9. PubMed ID: 25066760
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape.
    Han Q, Zhao H, Jiang Y, Yin C, Zhang J.
    Cells; 2019 Jun 08; 8(6):. PubMed ID: 31181729
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.